Topic Code
HORIZON-HLTH-2026-01-IND-03
F&T Portal
Call Identifier
HORIZON-HLTH-2026-01
Call 01 — single stage (2026)
Instrument
HORIZON-RIA
Research and Innovation Action
Budget Model
Lump Sum
HORIZON-AG-LS
Funding Rate
100%
Annex G — RIA = 100%
Page Limit (Part B)
45 pages
RIA + lump sum (Annex A)
Evaluation Thresholds
4 / 4 / 4 · cum. 12
Non-standard — topic override
Expected Projects
4
€4–6M per project (WP stated)
Destination
Maintaining an innovative, sustainable, and competitive EU health industry
WP Part 4
Cluster / Pillar
Cluster 1 / Pillar II
Health
China Eligibility
Excluded ⚠
Destination excludes RIA/IA
Special Conditions
Non-standard thresholds ⚠
4/4/4 cum. 12 — not default 3/3/3
Chinese entities are excluded from RIA actions under this destination. Legal entities established in China are not eligible to participate in Research and Innovation Actions (RIAs) falling under Destination ‘Maintaining an innovative, sustainable, and competitive EU health industry’.
This topic uses non-standard evaluation thresholds: 4 (Excellence) / 4 (Impact) / 4 (Implementation), cumulative 12. Standard thresholds are 3/3/3 cumulative 10.
Communication networks restriction: Entities assessed as high-risk suppliers of mobile network communication equipment (and entities they own or control) are not eligible to participate in this topic.
US entities eligible: In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America are eligible to receive Union funding under this topic.
Copernicus/Galileo: If the project uses satellite-based earth observation, positioning, navigation and/or related timing data, beneficiaries must make use of Copernicus and/or Galileo/EGNOS.
Expected Outcomes
- Policymakers and regulators will get accelerated access to improved evidence driven methodologies to evaluate the impact and efficiency of novel health technologies, facilitating decision-making for their use in humans and uptake in clinical practice.
- Patients and the health systems will benefit from the more targeted and efficient uptake of safe and effective health innovations in clinical practice, supporting more personalised approaches and improved care and public health.
Want the full analysis?
The key facts above tell you WHAT. The full Decision Brief tells you HOW to win.
Compliance traps
Scoring playbook
Consortium blueprint
Positioning guide
Red flags
Quick-start checklist
Order Full Brief — €79
Delivered within 1 working day